Ann Intern Med

1. DACSO CC
   Coadministration of RSV + influenza or COVID-19 vaccines was noninferior to separate administration for immune responses in adults aged >/=50 y.
   Ann Intern Med. 2025 Apr 1. doi: 10.7326/ANNALS-25-00904.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

2. PANG Y, Li H, Chen X, Cao Y, et al
   A phase I, single-center, randomized, open-label, three-period crossover study to evaluate the drug-drug interaction between ZSP1273 and oseltamivir in healthy Chinese subjects.
   Antimicrob Agents Chemother. 2025;69:e0172924.
   

   >> Share

   
   
3. ZHAO L, Li C, Wang M, Zhou M, et al
   Potent antiviral activity of simnotrelvir against key epidemic SARS-CoV-2 variants with a high resistance barrier.
   Antimicrob Agents Chemother. 2025 Mar 10:e0155624. doi: 10.1128/aac.01556.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

4. LIU HL, Lin S, Hung W, Chang DC, et al
   A novel replicase-mediated self-amplifying RNA amplification mechanism of the SARS-CoV-2 replication-transcription system.
   Biochem Biophys Res Commun. 2025;758:151654.
   

   >> Share

   
   

   
   Biochemistry

5. E SANTO AA, Reis A, Pinheiro AA, da Costa PI, et al
   Design of Mimetic Antibodies Targeting the SARS-CoV-2 Spike Glycoprotein Based on the GB1 Domain: A Molecular Simulation and Experimental Study.
   Biochemistry. 2025;64:1541-1549.
   

   >> Share

   
   

   
   BMC Pediatr

6. JAFARI N, Akbari H, Maghsoodi A, Sarbakhsh P, et al
   The attitude of the unvaccinated children's parents toward pediatric COVID-19 vaccination in Tabriz, Iran.
   BMC Pediatr. 2025;25:248.
   

   >> Share

   
   

   
   Epidemiol Infect

7. MONGE S, Humphreys J, Nicolay N, Braeye T, et al
   Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23.
   Epidemiol Infect. 2025;153:e54.
   

   >> Share

   
   
8. MIN KH, Kim JH, Gil JY, Park JH, et al
   Factors associated with carditis adverse events following SARS-COV-2-19 vaccination.
   Epidemiol Infect. 2025;153:e51.
   

   >> Share

   
   

   
   J Exp Med

9. MADSEN A, Okba NMA, Pholcharee T, Matz HC, et al
   Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody.
   J Exp Med. 2025;222:e20241930.
   

   >> Share

   
   

   
   J Infect Dis

10. FRUTOS AM, Tenforde MW, Sundaresan D, Naleway AL, et al
    Influenza-associated hospitalization rates by underlying conditions, 2016-17 to 2019-20: A retrospective cohort study.
    J Infect Dis. 2025 Mar 28:jiaf164. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

11. XIAO X, Wang X, Xu F, Liang Y, et al
    Synergistic effects of PA (S184N) and PB2 (E627K) mutations on the increased pathogenicity of H3N2 canine influenza virus infections in mice and dogs.
    J Virol. 2025 Apr 4:e0198424. doi: 10.1128/jvi.01984.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

12. JOBE NB, Rose E, Winn AK, Goldstein L, et al
    Human Metapneumovirus Seasonality and Co-Circulation with Respiratory Syncytial Virus - United States, 2014-2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:182-187.
    

    >> Share

    
    

    
    Pediatrics

13. ROWE SL, Sullivan SG, Munoz FM, Coates MM, et al
    COVID-19 Vaccination During Pregnancy and Major Structural Birth Defects.
    Pediatrics. 2025 Mar 14:e2024069778. doi: 10.1542/peds.2024-069778.
    

    >> Share

    
    
14. COLEY RL, Leer J, Lanteri L
    Trends in Mental and Behavioral Health Risks in Adolescents: 1999-2021.
    Pediatrics. 2025;155:e2024068774.
    

    >> Share

    
    
15. DESILVA MB, Haapala J, Vazquez-Benitez G, Daley MF, et al
    COVID-19 and Completion of Select Routine Childhood Vaccinations.
    Pediatrics. 2025 Mar 26:e2024068244. doi: 10.1542/peds.2024-068244.
    

    >> Share

    
    

    
    PLoS Comput Biol

16. VON HOENE E, Roess A, Kavak H, Anderson T, et al
    Synthetic population generation with public health characteristics for spatial agent-based models.
    PLoS Comput Biol. 2025;21:e1012439.
    

    >> Share

    
    
17. WU L, Baker CM, Tierney N, Carville K, et al
    Quantifying the impact of contact tracing interview prioritisation strategies on disease transmission: A modelling study.
    PLoS Comput Biol. 2025;21:e1012906.
    

    >> Share

    
    

    
    PLoS One

18. JOSEPH M, Li Q, Shin S
    Health diagnosis associated with COVID-19 death in the United States: A retrospective cohort study using electronic health records.
    PLoS One. 2025;20:e0319585.
    

    >> Share

    
    
19. BAYOU FD, Getaneh FB, Asmare L, Endawkie A, et al
    Trend of home birth and its associated factors in Ethiopia during COVID-19 and social crisis (2019-2023).
    PLoS One. 2025;20:e0320859.
    

    >> Share

    
    
20. BUGHIN J, Cincera M, Reykowska D, Zyszkiewicz M, et al
    The great divide between employees: Clustering employee "well-being" during a pandemic.
    PLoS One. 2025;20:e0294540.
    

    >> Share

    
    
21. PARK H, Miyano S
    Computational network biology analysis revealed COVID-19 severity markers: Molecular interplay between HLA-II with CIITA.
    PLoS One. 2025;20:e0319205.
    

    >> Share

    
    
22. YOON J, Kim S, Kwon CY, Kang JW, et al
    Kyungok-go for fatigue in patients with long COVID: Double-blind, randomized, multicenter, pilot clinical study protocol.
    PLoS One. 2025;20:e0319459.
    

    >> Share

    
    
23. LESTARI BW, Saptiningrum E, Huria L, Fikri AR, et al
    Pre-treatment direct costs for people with tuberculosis during the COVID-19 pandemic in different healthcare settings in Bandung, Indonesia.
    PLoS One. 2025;20:e0320401.
    

    >> Share

    
    
24. YAGIHASHI M, Sakuma A, Murakami M
    Psychotherapies and psychological support for individuals facing psychological distress during the COVID-19 pandemic: A scoping review.
    PLoS One. 2025;20:e0318192.
    

    >> Share

    
    
25. CARMOLA LR, Roebling AD, Khosravi D, Langsjoen RM, et al
    Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA.
    PLoS One. 2025;20:e0317972.
    

    >> Share

    
    
26. LIU Y, She R, Xing J
    Analysis of University Students' Mental Health from the Perspective of Occupational Harmony.
    PLoS One. 2025;20:e0309490.
    

    >> Share

    
    
27. GKEKAS A, Ronaldson SJ, Parker A, Torgerson DJ, et al
    Improving patient recruitment to randomised trials can be cost-effective: A case-study of dexamethasone from the RECOVERY trial.
    PLoS One. 2025;20:e0314593.
    

    >> Share

    
    
28. SURACE A, Munroe C, Martinez P
    "My drinking was way worse during the pandemic": A qualitative analysis of contextual and individual factors impacting alcohol use during the COVID-19 pandemic.
    PLoS One. 2025;20:e0319977.
    

    >> Share

    
    
29. AIZAWA T
    Socio-economic gradients in hypertension and diabetes management amid the COVID-19 pandemic in India.
    PLoS One. 2025;20:e0315867.
    

    >> Share

    
    
30. TAO Z, Ramasamy SS, Naktnasukanjn N, Ying F, et al
    Assessing competitiveness and complementarity in agricultural trade between China and Cambodia pre-pandemic and post-pandemic.
    PLoS One. 2025;20:e0321081.
    

    >> Share

    
    
31. TREPTOW M, Bartels C, Ruhleder M, Kratzenberg A, et al
    Divergent psychological stress response patterns to the COVID-19 pandemic in psychiatric patients with vs. without PTSD: A real-world exploratory study.
    PLoS One. 2025;20:e0318839.
    

    >> Share

    
    
32. STUKAS S, Goshua G, Conway EM, Lee AYY, et al
    ABO blood group and COVID-19 severity: Associations with endothelial and adipocyte activation in critically ill patients.
    PLoS One. 2025;20:e0320251.
    

    >> Share

    
    
33. AWASTHI S, Dehkharghani MZ, Fudolig M
    Emergence to dominance: Estimating time to dominance of SARS-CoV-2 variants using nonlinear statistical models.
    PLoS One. 2025;20:e0311459.
    

    >> Share

    
    
34. MITCHELL E, Are EB, Colijn C, Earn DJD, et al
    Using artificial intelligence tools to automate data extraction for living evidence syntheses.
    PLoS One. 2025;20:e0320151.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

35. GUAY B, Marghetis T, Wong C, Landy D, et al
    Quirks of cognition explain why we dramatically overestimate the size of minority groups.
    Proc Natl Acad Sci U S A. 2025;122:e2413064122.
    

    >> Share

    
    

    
    Vaccine

36. OTORBAEVA D, Akmatova R, Cooley KM, Iwamoto C, et al
    Post-introduction evaluation (PIE) of the seasonal influenza vaccination program in Kyrgyzstan in 2023.
    Vaccine. 2025;55:127052.
    

    >> Share

    
    

    
    Virology

37. ISHIGAKI H, Itoh Y
    Translational research on pandemic virus infection using nonhuman primate models.
    Virology. 2025;606:110511.
    

    >> Share

    
    
38. BANGA NDZOUBOUKOU JL, Kamara AA, Ullah N, Lei Q, et al
    A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults.
    Virology. 2025;606:110509.
    

    >> Share

    
    
39. DAS SARMA J
    Murine beta-coronavirus spike protein: A major determinant of neuropathogenic properties.
    Virology. 2025;606:110499.
    

    >> Share

    
    
40. LUNDRIGAN E, Uguccioni S, Hum C, Ahmed N, et al
    SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways.
    Virology. 2025;606:110493.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share